Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bittoo Kanwar, MD
Gilead Sciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
175 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Concord Repatriation General Hospital
Concord, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- Gallipoli Medical Research Foundation
Greenslopes, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Monash Medical Centre
Melbourne, Victoria, Australia
- B2 Clinic
Fremantle, Western Australia, Australia
- Canberra Hospital
Australian Capital Territory, Australia
- St. Vincent'S Hospital
Fitzroy, Australia
- Royal Brisbane & Women'S Hospital
Herston, Australia
- St George Hospital
Kogarah, Australia
- Royal Prince Alfred Hospital, Camperdown
NSW, Australia
- Royal Perth Hospital
Perth Western Australia, Australia
- Princess Alexandra Hospital
State of Queensland, Australia
- Box Hill Hospital
Victoria, Australia
- Medizinische Universität Graz
Graz, Austria
- Medizinische Universität Wien
Vienna, Austria
- Wilhelminenspital
Vienna, Austria
- University of Calgary
Calgary, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Gastrointestinal Research Institute (giri)
Vancouver, British Columbia, Canada
- Vancouver Infectious Disease Research and Care Centre
Vancouver, British Columbia, Canada
- John Buhler Research Center
Winnipeg, Manitoba, Canada
- Mount Sinai Hospital
Toronto, Ontario, Canada
- Toronto Liver Centre
Toronto, Ontario, Canada
- Toronto Western Hospital
Toronto, Ontario, Canada
- Toronto Western Hospital
Toronto, Ontario, Canada
- Toronto Digestive Diseases Associates, Inc
Vaughan, Ontario, Canada
- Hopital St. Luc
Montreal, Quebec, Canada
- Gordon & Leslie Diamond Health Care Centre
Vancouver, Canada
- Remedis S.R.O., Nestátní Zdravotnické Zarízení
Prague, Czechia
- West Tallinn Central Hospital
Tallinn, Estonia
- Tartu University Hospital
Tartu, Estonia
- Chu Estaing
Clermont-Ferrand, France
- Centre Hospitalier Universitaire de Clermont-Ferrand
Clermont-Ferrand, France
- Hôpital Beaujon
Clichy, France
- Hôpital Henri Mondor
Créteil, France
- Hôpital Claude Huriez- Service D'Hépato-Gastroentérologie
Lille, France
- Hôpital Saint Joseph
Marseille, France
- Hopital Saint Eloi
Montpellier, France
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2012
- Primary completion
- 31 Oct 2014
- Completion
- 31 Dec 2014
- Last update posted
- 9 Nov 2015
- Registered enrollment
- 534
- Registry id
- NCT01625338
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.